Since both of the two sites locate in the phosphatidylethanolamine-binding domain, PEBP proteolysis by calpain might disrupt its original roles to alleviate impaired proteasome function in Alzheimer's disease (AD) [30]. Here, PEBP1 is linked to early-onset autosomal dominant Alzheimer disease.